Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.
Identifieur interne : 002584 ( PubMed/Curation ); précédent : 002583; suivant : 002585Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.
Auteurs : A S Mustafa [Koweït] ; F A Shaban ; A T Abal ; R. Al-Attiyah ; H G Wiker ; K E Lundin ; F. Oftung ; K. HuygenSource :
- Infection and immunity [ 0019-9567 ] ; 2000.
Descripteurs français
- KwdFr :
- Activation des lymphocytes, Acyltransferases, Antigènes HLA, Antigènes bactériens (génétique), Données de séquences moléculaires, Humains, Lignée cellulaire, Lymphocytes T CD4+ (immunologie), Lymphocytes auxiliaires Th1 (immunologie), Mycobacterium tuberculosis (génétique), Mycobacterium tuberculosis (immunologie), Protéines bactériennes (génétique), Protéines bactériennes (immunologie), Présentation d'antigène, Similitude de séquences d'acides aminés, Séquence d'acides aminés, Tuberculose pulmonaire (immunologie), Vaccin BCG (immunologie), Épitopes (génétique).
- MESH :
- génétique : Antigènes bactériens, Mycobacterium tuberculosis, Protéines bactériennes, Épitopes.
- immunologie : Lymphocytes T CD4+, Lymphocytes auxiliaires Th1, Mycobacterium tuberculosis, Protéines bactériennes, Tuberculose pulmonaire, Vaccin BCG.
- Activation des lymphocytes, Acyltransferases, Antigènes HLA, Données de séquences moléculaires, Humains, Lignée cellulaire, Présentation d'antigène, Similitude de séquences d'acides aminés, Séquence d'acides aminés.
English descriptors
- KwdEn :
- Acyltransferases, Amino Acid Sequence, Antigen Presentation, Antigens, Bacterial (genetics), BCG Vaccine (immunology), Bacterial Proteins (genetics), Bacterial Proteins (immunology), CD4-Positive T-Lymphocytes (immunology), Cell Line, Epitopes (genetics), HLA Antigens, Humans, Lymphocyte Activation, Molecular Sequence Data, Mycobacterium tuberculosis (genetics), Mycobacterium tuberculosis (immunology), Sequence Homology, Amino Acid, Th1 Cells (immunology), Tuberculosis, Pulmonary (immunology).
- MESH :
- chemical , genetics : Antigens, Bacterial, Bacterial Proteins, Epitopes.
- chemical , immunology : BCG Vaccine, Bacterial Proteins.
- chemical : Acyltransferases, HLA Antigens.
- genetics : Mycobacterium tuberculosis.
- immunology : CD4-Positive T-Lymphocytes, Mycobacterium tuberculosis, Th1 Cells, Tuberculosis, Pulmonary.
- Amino Acid Sequence, Antigen Presentation, Cell Line, Humans, Lymphocyte Activation, Molecular Sequence Data, Sequence Homology, Amino Acid.
Abstract
Antigen 85B (Ag85B/MPT59) is a major secreted protein from Mycobacterium tuberculosis which is a promising candidate antigen for inclusion in novel subunit vaccines against tuberculosis (TB). The present study was undertaken to map naturally derived T-cell epitopes from M. tuberculosis Ag85B in relation to major histocompatibility complex (MHC) class II restriction. Antigen-specific CD4(+) T-cell lines were established from HLA-typed TB patients and Mycobacterium bovis BCG vaccinees by stimulation of peripheral blood mononuclear cells with purified Ag85B in vitro. The established T-cell lines were then tested for proliferation and gamma interferon (IFN-gamma) secretion in response to 31 overlapping synthetic peptides (18-mers) covering the entire sequence of the mature protein. The results showed that the epitopes recognized by T-cell lines from TB patients were scattered throughout the Ag85B sequence whereas the epitopes recognized by T-cell lines from BCG vaccinees were located toward the N-terminal part of the antigen. The T-cell epitopes represented by peptides p2 (amino acids [aa] 10 to 27), p3 (aa 19 to 36), and p11 (aa 91 to 108) were frequently recognized by antigen-specific T-cell lines from BCG vaccinees in both proliferation and IFN-gamma assays. MHC restriction analysis demonstrated that individual T-cell lines specifically recognized the complete Ag85B either in association with one of the self HLA-DRB1, DRB3, or DRB4 gene products or nonspecifically in a promiscuous manner. At the epitope level, panel studies showed that peptides p2, p3, and p11 were presented to T cells by HLA-DR-matched as well as mismatched allogeneic antigen-presenting cells, thus representing promiscuous epitopes. The identification of naturally derived peptide epitopes from the M. tuberculosis Ag85B presented to Th1 cells in the context of multiple HLA-DR molecules strongly supports the relevance of this antigen to subunit vaccine design.
DOI: 10.1128/iai.68.7.3933-3940.2000
PubMed: 10858206
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002584
Links to Exploration step
pubmed:10858206Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.</title><author><name sortKey="Mustafa, A S" sort="Mustafa, A S" uniqKey="Mustafa A" first="A S" last="Mustafa">A S Mustafa</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait. abusalim@hsc.kuniv.edu.kw</nlm:affiliation><country xml:lang="fr">Koweït</country><wicri:regionArea>Department of Microbiology, Faculty of Medicine, Kuwait University</wicri:regionArea></affiliation></author><author><name sortKey="Shaban, F A" sort="Shaban, F A" uniqKey="Shaban F" first="F A" last="Shaban">F A Shaban</name></author><author><name sortKey="Abal, A T" sort="Abal, A T" uniqKey="Abal A" first="A T" last="Abal">A T Abal</name></author><author><name sortKey="Al Attiyah, R" sort="Al Attiyah, R" uniqKey="Al Attiyah R" first="R" last="Al-Attiyah">R. Al-Attiyah</name></author><author><name sortKey="Wiker, H G" sort="Wiker, H G" uniqKey="Wiker H" first="H G" last="Wiker">H G Wiker</name></author><author><name sortKey="Lundin, K E" sort="Lundin, K E" uniqKey="Lundin K" first="K E" last="Lundin">K E Lundin</name></author><author><name sortKey="Oftung, F" sort="Oftung, F" uniqKey="Oftung F" first="F" last="Oftung">F. Oftung</name></author><author><name sortKey="Huygen, K" sort="Huygen, K" uniqKey="Huygen K" first="K" last="Huygen">K. Huygen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:10858206</idno><idno type="pmid">10858206</idno><idno type="doi">10.1128/iai.68.7.3933-3940.2000</idno><idno type="wicri:Area/PubMed/Corpus">002584</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002584</idno><idno type="wicri:Area/PubMed/Curation">002584</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002584</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.</title><author><name sortKey="Mustafa, A S" sort="Mustafa, A S" uniqKey="Mustafa A" first="A S" last="Mustafa">A S Mustafa</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait. abusalim@hsc.kuniv.edu.kw</nlm:affiliation><country xml:lang="fr">Koweït</country><wicri:regionArea>Department of Microbiology, Faculty of Medicine, Kuwait University</wicri:regionArea></affiliation></author><author><name sortKey="Shaban, F A" sort="Shaban, F A" uniqKey="Shaban F" first="F A" last="Shaban">F A Shaban</name></author><author><name sortKey="Abal, A T" sort="Abal, A T" uniqKey="Abal A" first="A T" last="Abal">A T Abal</name></author><author><name sortKey="Al Attiyah, R" sort="Al Attiyah, R" uniqKey="Al Attiyah R" first="R" last="Al-Attiyah">R. Al-Attiyah</name></author><author><name sortKey="Wiker, H G" sort="Wiker, H G" uniqKey="Wiker H" first="H G" last="Wiker">H G Wiker</name></author><author><name sortKey="Lundin, K E" sort="Lundin, K E" uniqKey="Lundin K" first="K E" last="Lundin">K E Lundin</name></author><author><name sortKey="Oftung, F" sort="Oftung, F" uniqKey="Oftung F" first="F" last="Oftung">F. Oftung</name></author><author><name sortKey="Huygen, K" sort="Huygen, K" uniqKey="Huygen K" first="K" last="Huygen">K. Huygen</name></author></analytic><series><title level="j">Infection and immunity</title><idno type="ISSN">0019-9567</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acyltransferases</term><term>Amino Acid Sequence</term><term>Antigen Presentation</term><term>Antigens, Bacterial (genetics)</term><term>BCG Vaccine (immunology)</term><term>Bacterial Proteins (genetics)</term><term>Bacterial Proteins (immunology)</term><term>CD4-Positive T-Lymphocytes (immunology)</term><term>Cell Line</term><term>Epitopes (genetics)</term><term>HLA Antigens</term><term>Humans</term><term>Lymphocyte Activation</term><term>Molecular Sequence Data</term><term>Mycobacterium tuberculosis (genetics)</term><term>Mycobacterium tuberculosis (immunology)</term><term>Sequence Homology, Amino Acid</term><term>Th1 Cells (immunology)</term><term>Tuberculosis, Pulmonary (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Activation des lymphocytes</term><term>Acyltransferases</term><term>Antigènes HLA</term><term>Antigènes bactériens (génétique)</term><term>Données de séquences moléculaires</term><term>Humains</term><term>Lignée cellulaire</term><term>Lymphocytes T CD4+ (immunologie)</term><term>Lymphocytes auxiliaires Th1 (immunologie)</term><term>Mycobacterium tuberculosis (génétique)</term><term>Mycobacterium tuberculosis (immunologie)</term><term>Protéines bactériennes (génétique)</term><term>Protéines bactériennes (immunologie)</term><term>Présentation d'antigène</term><term>Similitude de séquences d'acides aminés</term><term>Séquence d'acides aminés</term><term>Tuberculose pulmonaire (immunologie)</term><term>Vaccin BCG (immunologie)</term><term>Épitopes (génétique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Bacterial</term><term>Bacterial Proteins</term><term>Epitopes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>BCG Vaccine</term><term>Bacterial Proteins</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Acyltransferases</term><term>HLA Antigens</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Mycobacterium tuberculosis</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes bactériens</term><term>Mycobacterium tuberculosis</term><term>Protéines bactériennes</term><term>Épitopes</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lymphocytes T CD4+</term><term>Lymphocytes auxiliaires Th1</term><term>Mycobacterium tuberculosis</term><term>Protéines bactériennes</term><term>Tuberculose pulmonaire</term><term>Vaccin BCG</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term><term>Mycobacterium tuberculosis</term><term>Th1 Cells</term><term>Tuberculosis, Pulmonary</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term><term>Antigen Presentation</term><term>Cell Line</term><term>Humans</term><term>Lymphocyte Activation</term><term>Molecular Sequence Data</term><term>Sequence Homology, Amino Acid</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Activation des lymphocytes</term><term>Acyltransferases</term><term>Antigènes HLA</term><term>Données de séquences moléculaires</term><term>Humains</term><term>Lignée cellulaire</term><term>Présentation d'antigène</term><term>Similitude de séquences d'acides aminés</term><term>Séquence d'acides aminés</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Antigen 85B (Ag85B/MPT59) is a major secreted protein from Mycobacterium tuberculosis which is a promising candidate antigen for inclusion in novel subunit vaccines against tuberculosis (TB). The present study was undertaken to map naturally derived T-cell epitopes from M. tuberculosis Ag85B in relation to major histocompatibility complex (MHC) class II restriction. Antigen-specific CD4(+) T-cell lines were established from HLA-typed TB patients and Mycobacterium bovis BCG vaccinees by stimulation of peripheral blood mononuclear cells with purified Ag85B in vitro. The established T-cell lines were then tested for proliferation and gamma interferon (IFN-gamma) secretion in response to 31 overlapping synthetic peptides (18-mers) covering the entire sequence of the mature protein. The results showed that the epitopes recognized by T-cell lines from TB patients were scattered throughout the Ag85B sequence whereas the epitopes recognized by T-cell lines from BCG vaccinees were located toward the N-terminal part of the antigen. The T-cell epitopes represented by peptides p2 (amino acids [aa] 10 to 27), p3 (aa 19 to 36), and p11 (aa 91 to 108) were frequently recognized by antigen-specific T-cell lines from BCG vaccinees in both proliferation and IFN-gamma assays. MHC restriction analysis demonstrated that individual T-cell lines specifically recognized the complete Ag85B either in association with one of the self HLA-DRB1, DRB3, or DRB4 gene products or nonspecifically in a promiscuous manner. At the epitope level, panel studies showed that peptides p2, p3, and p11 were presented to T cells by HLA-DR-matched as well as mismatched allogeneic antigen-presenting cells, thus representing promiscuous epitopes. The identification of naturally derived peptide epitopes from the M. tuberculosis Ag85B presented to Th1 cells in the context of multiple HLA-DR molecules strongly supports the relevance of this antigen to subunit vaccine design.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10858206</PMID><DateCompleted><Year>2000</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-9567</ISSN><JournalIssue CitedMedium="Print"><Volume>68</Volume><Issue>7</Issue><PubDate><Year>2000</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Infection and immunity</Title><ISOAbbreviation>Infect. Immun.</ISOAbbreviation></Journal><ArticleTitle>Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.</ArticleTitle><Pagination><MedlinePgn>3933-40</MedlinePgn></Pagination><Abstract><AbstractText>Antigen 85B (Ag85B/MPT59) is a major secreted protein from Mycobacterium tuberculosis which is a promising candidate antigen for inclusion in novel subunit vaccines against tuberculosis (TB). The present study was undertaken to map naturally derived T-cell epitopes from M. tuberculosis Ag85B in relation to major histocompatibility complex (MHC) class II restriction. Antigen-specific CD4(+) T-cell lines were established from HLA-typed TB patients and Mycobacterium bovis BCG vaccinees by stimulation of peripheral blood mononuclear cells with purified Ag85B in vitro. The established T-cell lines were then tested for proliferation and gamma interferon (IFN-gamma) secretion in response to 31 overlapping synthetic peptides (18-mers) covering the entire sequence of the mature protein. The results showed that the epitopes recognized by T-cell lines from TB patients were scattered throughout the Ag85B sequence whereas the epitopes recognized by T-cell lines from BCG vaccinees were located toward the N-terminal part of the antigen. The T-cell epitopes represented by peptides p2 (amino acids [aa] 10 to 27), p3 (aa 19 to 36), and p11 (aa 91 to 108) were frequently recognized by antigen-specific T-cell lines from BCG vaccinees in both proliferation and IFN-gamma assays. MHC restriction analysis demonstrated that individual T-cell lines specifically recognized the complete Ag85B either in association with one of the self HLA-DRB1, DRB3, or DRB4 gene products or nonspecifically in a promiscuous manner. At the epitope level, panel studies showed that peptides p2, p3, and p11 were presented to T cells by HLA-DR-matched as well as mismatched allogeneic antigen-presenting cells, thus representing promiscuous epitopes. The identification of naturally derived peptide epitopes from the M. tuberculosis Ag85B presented to Th1 cells in the context of multiple HLA-DR molecules strongly supports the relevance of this antigen to subunit vaccine design.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>A S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait. abusalim@hsc.kuniv.edu.kw</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaban</LastName><ForeName>F A</ForeName><Initials>FA</Initials></Author><Author ValidYN="Y"><LastName>Abal</LastName><ForeName>A T</ForeName><Initials>AT</Initials></Author><Author ValidYN="Y"><LastName>Al-Attiyah</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Wiker</LastName><ForeName>H G</ForeName><Initials>HG</Initials></Author><Author ValidYN="Y"><LastName>Lundin</LastName><ForeName>K E</ForeName><Initials>KE</Initials></Author><Author ValidYN="Y"><LastName>Oftung</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Huygen</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Immun</MedlineTA><NlmUniqueID>0246127</NlmUniqueID><ISSNLinking>0019-9567</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001500">BCG Vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.-</RegistryNumber><NameOfSubstance UI="D000217">Acyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.-</RegistryNumber><NameOfSubstance UI="C121433">antigen 85B, Mycobacterium tuberculosis</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000217" MajorTopicYN="Y">Acyltransferases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017951" MajorTopicYN="N">Antigen Presentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000942" MajorTopicYN="Y">Antigens, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001500" MajorTopicYN="N">BCG Vaccine</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018417" MajorTopicYN="N">Th1 Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>6</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>7</Month><Day>25</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>6</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10858206</ArticleId><ArticleId IdType="pmc">PMC101670</ArticleId><ArticleId IdType="doi">10.1128/iai.68.7.3933-3940.2000</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Lepr Other Mycobact Dis. 1989 Mar;57(1):1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">2659694</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1999 Nov;67(11):5683-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10531216</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1981 Mar;31(3):1152-60</Citation><ArticleIdList><ArticleId IdType="pubmed">7014457</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 1983 Apr;52(1):29-37</Citation><ArticleIdList><ArticleId IdType="pubmed">6190596</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1986 Jan 2-8;319(6048):63-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3510397</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 1985 Dec;62(3):474-81</Citation><ArticleIdList><ArticleId IdType="pubmed">2935339</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1986 Sep;53(3):491-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2427449</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Lepr Other Mycobact Dis. 1987 Mar;55(1):30-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3549938</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepr Rev. 1986 Dec;57 Suppl 2:123-30</Citation><ArticleIdList><ArticleId IdType="pubmed">3106732</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 1987 Aug;69(2):255-62</Citation><ArticleIdList><ArticleId IdType="pubmed">2958195</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Immunol. 1988 Feb;27(2):187-94</Citation><ArticleIdList><ArticleId IdType="pubmed">3124263</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Lepr Other Mycobact Dis. 1988 Jun;56(2):265-73</Citation><ArticleIdList><ArticleId IdType="pubmed">3045224</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1988 Oct 15;141(8):2749-54</Citation><ArticleIdList><ArticleId IdType="pubmed">2459228</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1990 Feb 15;144(4):1478-83</Citation><ArticleIdList><ArticleId IdType="pubmed">1689354</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1991 Jan;59(1):372-82</Citation><ArticleIdList><ArticleId IdType="pubmed">1898899</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Microbiol. 1991 Apr;137(4):875-84</Citation><ArticleIdList><ArticleId IdType="pubmed">1906925</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1991 Sep;59(9):3205-12</Citation><ArticleIdList><ArticleId IdType="pubmed">1715324</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1992 Jan 1;148(1):189-96</Citation><ArticleIdList><ArticleId IdType="pubmed">1727865</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Microbiol. 1992 Jan;6(2):133-45</Citation><ArticleIdList><ArticleId IdType="pubmed">1545700</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12013-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1465432</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Rev. 1992 Dec;56(4):648-61</Citation><ArticleIdList><ArticleId IdType="pubmed">1480113</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 1993 Jan;41(1):55-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8456444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1993 Jul 1;151(1):518-25</Citation><ArticleIdList><ArticleId IdType="pubmed">8100846</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1993 Aug;61(8):3482-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8335379</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1993 Dec;61(12):5294-301</Citation><ArticleIdList><ArticleId IdType="pubmed">8225603</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1993 Dec 1;178(6):2249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">7504064</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1993;11(11):1108-12</Citation><ArticleIdList><ArticleId IdType="pubmed">7504379</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1994 Feb;62(2):363-70</Citation><ArticleIdList><ArticleId IdType="pubmed">7507889</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1994 Sep;62(9):3679-87</Citation><ArticleIdList><ArticleId IdType="pubmed">7520418</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1994 Dec;62(12):5319-26</Citation><ArticleIdList><ArticleId IdType="pubmed">7525483</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1994 Dec;62(12):5411-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7525484</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1994 Dec;62(12):5595-602</Citation><ArticleIdList><ArticleId IdType="pubmed">7525488</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1995 Apr 1;154(7):3359-72</Citation><ArticleIdList><ArticleId IdType="pubmed">7897219</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1995 May 1;154(9):4665-74</Citation><ArticleIdList><ArticleId IdType="pubmed">7722319</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Immunol. 1995 May;41(5):433-42</Citation><ArticleIdList><ArticleId IdType="pubmed">7725062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1995 Nov 18;346(8986):1339-45</Citation><ArticleIdList><ArticleId IdType="pubmed">7475776</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 1996 Mar;87(3):421-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8778028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 1996 Aug;2(8):893-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8705859</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1999 Mar;179(3):637-45</Citation><ArticleIdList><ArticleId IdType="pubmed">9952370</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1999 Apr;67(4):1702-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10085007</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1999 May;67(5):2665-70</Citation><ArticleIdList><ArticleId IdType="pubmed">10225940</ArticleId></ArticleIdList></Reference><Reference><Citation>FEMS Immunol Med Microbiol. 1999 Jun;24(2):151-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10378414</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrition. 1995 Sep-Oct;11(5 Suppl):665-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8748247</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Lepr Other Mycobact Dis. 1996 Sep;64(3):257-67</Citation><ArticleIdList><ArticleId IdType="pubmed">8862259</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Immunol. 1997 Feb;45(2):115-31</Citation><ArticleIdList><ArticleId IdType="pubmed">9042423</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1997 Jun;15(8):830-3</Citation><ArticleIdList><ArticleId IdType="pubmed">9234526</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):270-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9419365</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1998 Jan;66(1):169-75</Citation><ArticleIdList><ArticleId IdType="pubmed">9423854</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1998 Jan;66(1):176-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9423855</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1998 Feb;66(2):830-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9453650</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Cell Biol. 1997 Dec;75(6):595-603</Citation><ArticleIdList><ArticleId IdType="pubmed">9492199</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1998 Apr;66(4):1527-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9529077</ArticleId></ArticleIdList></Reference><Reference><Citation>FEMS Immunol Med Microbiol. 1998 Mar;20(3):231-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9566494</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Immunol. 1998 Nov;48(5):535-43</Citation><ArticleIdList><ArticleId IdType="pubmed">9822264</ArticleId></ArticleIdList></Reference><Reference><Citation>FEMS Immunol Med Microbiol. 1998 Nov;22(3):205-16</Citation><ArticleIdList><ArticleId IdType="pubmed">9848681</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 1998 Sep;95(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">9767459</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 1998 Dec;95(4):585-90</Citation><ArticleIdList><ArticleId IdType="pubmed">9893049</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002584 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002584 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:10858206
|texte= Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:10858206" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |